<DOC>
	<DOCNO>NCT00004138</DOCNO>
	<brief_summary>RATIONALE : Imaging procedure , positron emission tomography ( PET ) , may improve ability detect extent non-small cell lung cancer . PURPOSE : Diagnostic trial study effectiveness PET detect lesion patient newly diagnose stage I , stage II , stage IIIA non-small cell lung cancer .</brief_summary>
	<brief_title>Positron Emission Tomography Detecting Non-small Cell Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : Primary Objective : To ascertain whether FDG-PET scan detect lesion would preclude pulmonary resection patient find surgical candidate standard image procedure . Secondary Objectives : To use data collect generate hypothesis use future study , type previously undetected lesion FDG-PET best able identify . Patients receive fludeoxyglucose F 18 ( FDG ) IV follow 45-60 minute later positron emission tomography ( PET ) imaging . Confirmatory study , biopsy , fine needle aspiration , image study conduct confirm PET finding . Patients mediastinal nodal distant metastasis identify FDG-PET scan may undergo thoracotomy pulmonary resection within 1 month evaluation . Patients follow 5-6 month surgery .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Fluorodeoxyglucose F18</mesh_term>
	<criteria>1 . Patient must â‰¥ 18 year age . 2. ) Patient must histologically cytologically confirm , newly diagnose , untreated , single lesion bronchogenic NSCLC ( adenocarcinoma , nonlobar/non diffuse bronchioloalveolor cell carcinoma , large cell carcinoma , squamous cell carcinoma ) . OR b ) Patient eligible base upon mediastinal node histology diagnose transbronchial biopsy , separate ipsilateral lung lesion clearly evident radiograph , biopsy lung tumor require patient . OR c ) Patient may eligible without histologic cytologic proof ; The patient strongly suspect primary bronchogenic carcinoma ( e.g. , heavy smoker new peripheral mass typical appearance lung cancer chest radiograph although bronchoscopy and/or fine needle aspiration nondiagnostic ) , The tumor clinically resectable , An exploratory thoracotomy plan . 3 . Patient must medically fit surgical staging procedure follow thoracic surgeon 's evaluation general medical fitness . 4 . Patient must candidate resection clinical stage I , II , IIIa lesion . 5 . Patient must able tolerate PET , ( i.e. , claustrophobic able lie supine 1.5 hr ) . 6 . A signed date write informed consent must obtain patient patient 's legally acceptable representative prior study participation . 7 . Female patient childbearing potential must negative serum urine pregnancy test , 72 hour prior FDGPET . NOTE : This order avoid unnecessary fetal radiation exposure use furosemide contraindicate pregnancy . 8 . Patient must complete follow standard stag procedure 60 day prior registration . CT scan chest upper abdomen ( include adrenal ) contrast NOTE : Noncontrast CT scan may use patient peripheral suspicious nodule evidence hilar mediastinal adenopathy invasion central structure . All lesion require IV contrast . Bone scan CT scan brain without contrast MRI brain 9 . A cancer survivor eligible provide ALL follow criterion meet document : patient undergone potentially curative therapy prior malignancy , evidence prior malignancy least five year ( except completely resect cervical nonmelanoma skin cancer ) , patient deem treat physician low risk recurrence prior malignancy . 1 . Patient prior PET scan evaluation NSCLC . 2 . Patient evidence stage IIIB IV disease confirm diagnostic imaging chest Xray , CT chest , CT abdomen , CT brain MRI brain , bone scan . 3 . Patient uncontrolled diabetes mellitus , evidence fast blood glucose value &gt; 200 mg/dL , within 12 hour PET scan .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>stage I non-small cell lung cancer</keyword>
	<keyword>stage II non-small cell lung cancer</keyword>
	<keyword>squamous cell lung cancer</keyword>
	<keyword>large cell lung cancer</keyword>
	<keyword>stage IIIA non-small cell lung cancer</keyword>
	<keyword>adenocarcinoma lung</keyword>
	<keyword>bronchoalveolar cell lung cancer</keyword>
</DOC>